OSE Pharma's IPO

OSE Pharma raised a round of funding on March 31, 2015. Investors include Public.

OSE Pharma (Paris: OSE) is a biotechnology company that designs and develops cancer immunotherapy treatments aimed at re-educating the immune system to fight cancer while preserving patients' quality …

Articles about OSE Pharma's IPO: